Evotec SE (EVO) Operating Margin (2009 - 2025)
Evotec SE (EVO) posted Operating Margin of 14.92% for Q4 2025, up 154.96% sequentially from 27.15% in Q3 2025, and up 1239.0% YoY from 1.11% in Q4 2024.
Evotec SE (EVO) Operating Margin (2009 - 2025) Analysis & Trends
Evotec SE has reported Operating Margin for 9 years, with the latest figure at 14.92% in Q4 2025.
- Quarterly Operating Margin rose 1239.0% year-over-year to 14.92% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 3.36% (up 44.0% YoY) and the FY2025 annual result came in at 9449.52%, down 943164.0% from the prior year.
- Operating Margin improved to 14.92% in Q4 2025 per EVO's latest filing, from 27.15% in the prior quarter.
- Over five years, Operating Margin peaked at 38.98% in Q1 2021 and troughed at 27.15% in Q3 2025.
- A 5-year average of 4.07% and a median of 4.9% in 2021 frame the typical range for Operating Margin.
- The sharpest annual moves came in 2021 and 2025: Operating Margin sank 4013 bps in 2021, then soared 1239 bps in 2025.
- Over 5 years, Operating Margin stood at 6.05% in 2021, then slumped by 155 bps to 3.3% in 2022, then tumbled by 88 bps to 6.2% in 2023, then soared by 141 bps to 2.53% in 2024, then surged by 489 bps to 14.92% in 2025.
- According to Business Quant data, Operating Margin over the past three periods registered 14.92%, 27.15%, and 2.53% for Q4 2025, Q3 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.20 Bn | 43.24 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.43 Bn | 39.78 Bn | 2.15 Bn | -5.58% |
| 3 | Zoetis | 32.03 Bn | 30.35 Bn | 1.05 Bn | 33.91% |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | 16.51% |
| 5 | United Therapeutics | 22.42 Bn | 19.76 Bn | 683.80 Mn | 42.23% |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 0.17% |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | 15.80% |
| 8 | Elanco Animal Health | 12.05 Bn | 11.52 Bn | 798.00 Mn | 18.13% |
| 9 | Dr Reddys Laboratories | 10.08 Bn | 9.92 Bn | - | - |
| 10 | Evotec SE | 681.58 Mn | 681.10 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 14.92% |
| Sep 30, 2025 | -27.15% |
| Dec 31, 2024 | 2.53% |
| Sep 30, 2024 | -14.33% |
| Dec 31, 2023 | -6.20% |
| Sep 30, 2023 | 6.21% |
| Jun 30, 2023 | -16.99% |
| Dec 31, 2022 | -3.30% |
| Sep 30, 2022 | 7.78% |
| Jun 30, 2022 | -2.19% |
| Mar 31, 2022 | 38.78% |
| Dec 31, 2021 | 6.05% |
| Sep 30, 2021 | 11.11% |
| Jun 30, 2021 | 4.90% |
| Mar 31, 2021 | 38.98% |
| Dec 31, 2020 | 46.18% |
| Dec 31, 2019 | 14.05% |
| Sep 30, 2010 | 4.84% |
| Jun 30, 2010 | 12.01% |
| Mar 31, 2010 | -14.98% |